The Minimal Clinically Important Difference: Response
- PMID: 37917815
- DOI: 10.1177/03635465231189221
The Minimal Clinically Important Difference: Response
Conflict of interest statement
One or more of the authors has declared the following potential conflict of interest or source of funding: E.J.S. has received consulting fees from Arthrex, Smith & Nephew, Flexion Therapeutics, and Organogenesis; honoraria from FIDIA Pharma and Vericel; education support from Gotham Surgical Solutions; and hospitality payments from Liberty Surgical. G.G.L. has received education support from Arthrex and Gotham Surgical Solutions, and hospitality payments from Smith & Nephew. K.A.C. has received education support from Arthrex and hospitality payments from Flexion Therapeutics. M.J.A. has received education support and fees for other than consulting from Arthrex. L.M.J. has received consulting fees from DePuy Orthopaedics and Flexion Therapeutics, education support from Arthrex and Gotham Surgical Solutions, and hospitality payments from Horizon Therapeutics. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Comment on
-
The Minimal Clinically Important Difference Changes Greatly Based on the Different Calculation Methods.Am J Sports Med. 2023 Mar;51(4):1067-1073. doi: 10.1177/03635465231152484. Epub 2023 Feb 22. Am J Sports Med. 2023. PMID: 36811558 Free PMC article.
-
The Minimal Clinically Important Difference: Response.Am J Sports Med. 2023 Nov;51(13):NP52. doi: 10.1177/03635465231189222. Am J Sports Med. 2023. PMID: 37917816 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
